DARTS Experimental Plan — DHEA

Drug Affinity Responsive Target Stability · Cellular Target Identification

Phases

1Preparation
2DHEA Incubation
3Digestion
4Analysis

Combining Prediction and Experimentation

Don't use a single method alone. Combining in silico prediction → narrowing the list → experimental confirmation (DARTS + CETSA) is the most effective strategy.

Key Materials

PronaseDHEA StockNP-40PMSF

DARTS Principle

When DHEA binds to a target protein, the drug–protein interaction stabilizes the protein structure (thermodynamic stabilization). The target protein thus becomes more resistant to proteases compared to non-drug-bound proteins. After protease digestion, SDS-PAGE or MS is used to find bands/proteins that are more stable in the DHEA sample.

Lysis
DHEA Incubation
Digestion
SDS-PAGE
MS Identification
Molecular Weight
288.42 g/mol
Solvent
DMSO (≤0.1%)
Concentration
10 – 200 µM
Total Protein
2 – 5 mg/mL
Incubation Temp
4°C / 25°C
Classification
Molecular Docking

Stage 1 — Cell Lysate Preparation

1

Culture cells to appropriate density

Harvest 10⁷–10⁸ cells. Wash twice with cold PBS. Centrifuge 300 × g, 5 min, 4°C. Remove PBS completely.

2

Cell Lysis (Non-denaturing)

Add cold lysis buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40. Add PMSF 1 mM. Incubate on ice for 30 min, gentle agitation.

Important Note: Do not use protease inhibitor cocktail in the lysis buffer for DARTS experiments — only PMSF is needed. Full protease inhibitors will block the subsequent digestion step.